蛇毒神经生长因子对大鼠坐骨神经损伤功能修复的时效作用研究

为研究蛇毒神经生长因子 ( SNGF)对大鼠坐骨神经损伤的修复的时效作用 ,作者应用 Wistar大鼠 5 0只建立大鼠坐骨神经钳夹损伤模型 ,随机分为单纯损伤组、生理盐水对照组、SNGF治疗用药 1 4、 2 1、 2 8天组 ,每组 1 0只。 SNGF治疗各组按实验模型制备处理后 ,即刻在损伤神经周围肌肉注射 SNGF ( 90 0 Bu/kg) ,以后每天肌注 1次 ,连续给药 1 4、 2 1和 2 8天 ,而生理盐水对照组每天肌注等量生理盐水。结果通过展爪反射观察到 ,1 4天组术后 1 1天开始恢复 ,平均恢复时间 1 6天 ;2 1天组术后 1 1天开始恢复 ,平均恢复时间 1 5天 ;2 8天…     

Tropic 1808基因在大鼠损伤神经组织中的表达

目的观察Tropic 1808基因在大鼠正常和损伤坐骨神经组织中的表达,探讨Tropic 1808基因在周围神经损伤与再生过程中的作用.方法采用地高辛标记的Tropic 1808 cDNA探针、抗大鼠S-100蛋白抗体,以原位杂交和免疫组织化学双重染色法,观察Tropic 1808基因在正常和损伤大鼠坐骨神经组织中的表达.结果免疫组化结果显示,大鼠正常坐骨神经可表达S-100蛋白,但表达量较低;神经损伤后,其远侧端S-100蛋白的表达量明显增加.原位杂交结果显示,大鼠正常坐骨神经组织未见Tropic 1808 mRNA杂交信号;损伤神经的远侧端呈现较强的阳性信号,而且在部分S-100强阳性反应区可见Tropic 1808 mRNA杂交信号.结论 Tropic 1808基因在正常坐骨神经组织中未见表达;坐骨神经损伤后,其远侧端增殖的雪旺氏细胞可表达Tropic 1808 mRNA.提示,Tropic 1808是一种周围神经损伤后特异表达的基因.     

神经生长因子促进坐骨神经再生修复的酶组织化学研究

目的研究对兔右坐骨神经损伤后局部给予蛇毒神经生长因子(NGF),观察坐骨神经酶活性变化和超微结构的恢复情况,探讨NGF对神经再生的影响.方法乙酰胆碱酯酶(AChE)、酸性磷酸酶(ACPase)的酶组织化学技术和电镜技术.结果神经损伤后:AChE活性明显下降,NGF组的AChE活性恢复快于盐水对照组;ACPase活性逐渐增高,NGF组的ACPase活性恢复时间短于盐水对照组.坐骨神经的超微结构在神经损伤后也发生变化,NGF组的变化程度小于盐水对照组,恢复时间短于对照组.结论NGF可通过影响酶物质的代谢而起到加快受损神经恢复的作用.为临床上应用蛇毒NGF治疗周围神经损伤提供形态学依据.     

高压氧治疗创伤性脑损伤的效用及机制研究

目的:研究高压氧(HBO)对大鼠创伤性脑损伤(TBI)治疗效用并观察脑组织星形胶质细胞活化及胶质细胞源性神经营养因子(GDNF)和神经生长因子(NGF)表达的变化以探讨作用机制。方法:SD雄性大鼠54只,随机分为3组(n=18):假手术组、TBI组和HBO治疗组。采用Feeney法建立大鼠TBI模型,假手术组只开放骨窗,不予打击。HBO治疗组大鼠于脑损伤后6 h采用动物高压舱,以3ATA压力纯氧治疗60 min。TBI后48 h测量神经功能,然后分离脑组织,其中18只用干湿法测定脑含水量;18只脑组织用于切片,部分进行尼氏染色后作形态学观察,部分进行免疫组织化学染色,检测星形胶质细胞标记物胶质纤维酸性蛋白(GFAP)、波形蛋白(vimentin)与S100蛋白的表达;另18只大鼠取伤侧脑半球,进行Western blot分析,观察GDNF和NGF的表达。结果:HBO治疗能减轻神经功能障碍,降低脑含水量,减少海马部位神经细胞丢失,进一步激活损伤侧皮质与海马部位GFAP、vimentin与S-100阳性表达星形胶质细胞,促进损伤侧脑组织GDNF与NGF的表达。结论:HBO对创伤性脑损伤有较好治疗效果,其机制与上调GDNF和NGF的表达有关。     

肌注神经生长因子及血小板衍生生长因子对胫骨干闭合骨折大鼠早期骨愈合的影响及机制探究

摘要 目的：探讨肌肉注射神经生长因子（NGF）和血小板衍生生长因子（PDGF）对胫骨干闭合骨折大鼠早期骨愈合的效果及潜在机制。方法：采用随机数字表法将80只健康成年雄性SD大鼠分为模型组、NGF组、PDGF组和NGF+PDGF组,各20只。建立胫骨干闭合骨折模型后,给予NGF组大鼠肌注0.8 μg NGF;给予PDGF组大鼠肌注0.8 μg PDGF,给予NGF+PDGF组大鼠肌注0.8 μg NGF和0.8 μg PDGF;给予模型组大鼠肌注等体积生理盐水。分别在治疗第2周（T0）、第4周（T1）、第6周（T2）通过X线检查计算骨痂体积,采用酶联免疫吸附法检测血清中碱性磷酸酶（AKP）水平。颈椎脱臼法处死大鼠后采用苏木精-伊红（HE）染色观察胫骨骨折端病理学改变,采用实时荧光定量PCR法检测骨痂组织骨形态发生蛋白2（BMP2）、血管内皮生长因子（VEGF）和胰岛素样生长因子-1（IGF-1）mRNA相对表达水平。结果：NGF+PDGF组大鼠在T1时骨折断端愈合,骨痂体积大于其他三组;NGF组、PDGF组大鼠在T2时骨折断端愈合,骨痂体积大小均大于模型组（P<0.05）。模型组大鼠T2时骨折断端尚未完全愈合,骨痂体积显著大于其他三组（P<0.05）。NGF+PDGF组大鼠T0~T1时血清AKP水平均显著高于其他三组,NGF组和PDGF组大鼠血清AKP水平显著高于模型组（P<0.05）。T2时4组大鼠血清AKP水平比较无显著差异（P>0.05）。T1时,NGF组、PDGF组和NGF+PDGF组大鼠均可见骨小梁形态更加粗大、致密,呈栅栏状排列,骨小梁间的间隙变小,NGF+PDGF组大鼠骨断裂处被新生骨填满,NGF组、PDGF组骨断裂处仍有少量间隙。T1时NGF+PDGF组大鼠BMP2、VEGF和IGF-1相对表达水平均显著高于其他三组（P<0.05）,NGF组和PDGF组大鼠各指标mRNA相对表达水平比较无显著差异（P>0.05）,但均显著高于模型组（P<0.05）。T2时各组大鼠骨痂组织中BMP2、VEGF和IGF-1 mRNA相对表达水平比较无显著差异（P>0.05）。结论：NGF和PDGF对胫骨干闭合骨折大鼠早期骨愈合有协同促进作用,可能与促进BMP2、VEGF和IGF-1表达上调有关。     

黄体酮对大鼠面神经损伤轴突再生影响实验研究

为探讨黄体酮在大鼠面神经损伤再生修复中的作用,将48只雌性Wistar大鼠先切除双侧卵巢,2周后建立单侧面神经钳夹损伤动物模型.大鼠随机分为两组.A组为黄体酮组(实验组),术后每日臀部肌注黄体酮注射液0.2 mL;B组为对照组,术后每日注射等量的二甲基亚砜.1)分别在损伤后7、14、28 d时各组取面神经损伤处的远端经丽春红G-亮绿SF染色法光镜下观察,计算横断面单位面积的有髓神经纤维数目及髓鞘厚度.透射电镜下观察神经纤维超微结构变化;2)术后7、14、21、28 d时取大鼠损伤远端面神经行NGF(nerve growthfactor,NGF)蛋白免疫组织化学染色,观察NGF的表达情况.结果显示.有髓神经纤维计数及髓鞘厚度在术后各时间点实验组均多于对照组,两者差异有统计学意义(P＜0.05).NGF的表达在术后7、21、28 d时实验组多于对照组,但在术后14d时两组差异无统计学意义(P＞0.05).提示黄体酮促进面神经再生与其促进神经营养因子表达或运输有关.     

周围神经损伤后神经组织中Par-3蛋白表达和分布的变化

目的观察极性蛋白Par-3在损伤后神经组织中的表达和分布,探讨Par-3蛋白在周围神经损伤后髓鞘再生中的作用。方法 32只Sprague Dawley大鼠随机分为正常对照组、损伤组(坐骨神经损伤后第1、2、4、8周)。制备坐骨神经挤压伤模型,分别于损伤后各时间点,采用免疫组织化学法检测坐骨神经损伤远端Par-3蛋白的表达和分布。结果正常大鼠坐骨神经组织中即存在Par-3蛋白,但表达量少,且仅分布于Schwann细胞核内。坐骨神经损伤后,Par-3蛋白的表达和分布发生变化。损伤后1周,Par-3蛋白表达开始升高,Par-3散在分布于Schwann细胞核和细胞浆内。损伤后2周,神经组织中的Par-3蛋白达峰值,在Schwann细胞浆内呈不对称性分布似包绕轴突,呈新月形或C形。损伤后4周和8周,Par-3蛋白表达显著降低,神经组织中Par-3蛋白主要分布于Schwann细胞核内,胞浆内很少。结果 极性蛋白Par-3可能参与周围神经损伤后Schwann细胞的髓鞘再生。     

脂多糖干预对大鼠周围神经损伤后瓦勒变性的影响

目的探讨脂多糖对于大鼠坐骨神经损伤瓦勒变性早期髓鞘碎片清除的影响。方法将50只Wistar大鼠随机分成假手术组(10只),模型组(20只)和脂多糖LPS组(20只),LPS组及模型组横断大鼠右侧坐骨神经后,行神经外膜端端吻合;假手术组仅游离出坐骨神经,然后关闭切口。LPS组大鼠在神经断端显微注射LPS(2 g/L)1μL,模型组及假手术组大鼠注射同等体积生理盐水。于术后1.5、24 h和7 d取术侧坐骨神经。实时定量PCR(qRT-PCR)检测坐骨神经中白介素1β(IL-1β)mRNA、单核细胞趋化蛋白-1(MCP-1)mRNA水平;免疫荧光法检测坐骨神经中CD68+巨噬细胞的表达;HE染色观察坐骨神经的病理变化;油红O染色观察坐骨神经脱髓鞘程度;LFB染色观察坐骨神经髓鞘变化;坐骨神经功能指数(SFI)评价大鼠运动功能的恢复情况。结果实时定量PCR显示,与假手术组相比,术后1.5 h模型组IL-1βmRNA和MCP-1 mRNA的表达均明显升高(P0.001,P0.001),与模型组相比,术后1.5 h LPS组IL-1βmRNA和MCP-1mRNA的表达明显升高(P0.001,P0.001)。术后24 h模型组IL-1βmRNA和MCP-1m RNA的表达均明显升高(P0.001,P0.001),与模型组相比,术后24h LPS组IL-1βmRNA和MCP-1 mRNA的表达明显升高(P0.01,P0.01)。免疫荧光可见,与模型组相比,术后7 d LPS组中CD68+细胞表达显著上调(P0.05)。术后7 d坐骨神经HE染色可见,LPS组坐骨神经断端较多炎性细胞浸润,许旺细胞增殖活跃,模型组神经断端炎性细胞和许旺细胞较少。术后7 d坐骨神经ORO染色可见,与模型组相比,LPS组断端远侧脱髓鞘程度较高。术后7 d坐骨神经LFB染色可见,模型组和LPS组坐骨神经断端均出现脱髓鞘反应,但与模型组相比,LPS组神经断端残余髓鞘碎片明显减少(P0.05)。SFI显示,与模型组相比,LPS组大鼠在术后10、20、30、40和50 d分别不同程度升高,术后20 d明显增高,差异有显著性(P0.05)。结论脂多糖通过激活固有免疫系统加快大鼠坐骨周围神经损伤后瓦勒变性早期髓鞘碎片的清除。     

三七总皂苷对脊髓损伤后的保护作用及GFAP相关机制

目的:探讨三七总皂苷对脊髓损伤后的保护作用以及对GFAP表达变化的影响.方法:健康成年雌性SD大鼠63只,随机分为正常组,溶媒对照组,三七总皂苷组,大鼠脊髓T10右侧半横断损伤后15min,腹腔注射三七总皂苷,剂量为20mg.kg-1,以后每天给药一次,溶媒对照组注射等量生理盐水.术后1d,3d,7d,14d,21d,28d进行BBB评分行为学检测;动物存活1d、3d、7d、14d、 28d,运用免疫组织化学方法检测脊髓损伤远侧端GFAP表达的变化.结果:BBB评分显示,三七总皂苷能明显促进脊髓损伤后运动功能的恢复,其中损伤后7d和14d的评分明显高于溶媒对照组.免疫组化结果显示脊髓T10右侧半横断损伤后.脊髓远侧段 GFAP的表达损伤侧均强于对侧,损伤侧灰质GFAP的表达呈现出1d,3d逐渐增强,7d达高峰的趋势,14dGFAP的表达逐渐下降,至28d仍略高于正常组.三七总皂苷组和溶媒对照组相比,GFAP表达的时间趋势相同,但相同时间点GFAP的表达弱于对照组,尤其是3d、7d.结论:三七总皂苷能抑制脊髓半横断损伤后星形胶质细胞的活化,这可能是其促进脊髓损伤后运动功能恢复的机制之一.     

骨髓间充质干细胞与施万细胞联合移植对大鼠周围神经 损伤端侧吻合的修复效果研究

目的:探究骨髓间充质干细胞(MSCs)与施万细胞(SCs)联合移植对大鼠周围神经损伤端侧吻合的修复效果。方法:选取SD雌性大鼠60只均制作成坐骨神经损伤端侧吻合模型,并将其随机分为联合移植组、MSCs组和SCs组,分别对吻合端进行骨髓间充质干细胞与SCs联合移植、MSCs移植、SCs移植。观察分析三组大鼠的神经电生理学指标和腓神经功能指数(PFI)和神经传导速度(NCV)。结果:三组大鼠的PFI和NCV均有所改善,且联合移植组的PFI和NCV均优于其他两组,并随着时间推移损伤坐骨神经功能恢复越来越好。结论:MSCs与SCs均具有促进大鼠周围神经身上修复的功能,且两种细胞联合移植效果更加明显。     

The Protective Effects of Achyranthes bidentata Polypeptides on Rat Sciatic Nerve Crush Injury Causes Modulation of Neurotrophic Factors

Pharmacological treatment is a therapeutic approach to improving nerve regeneration and functional recovery after peripheral nerve crush injury. The objective of the present study was to investigate the effects of the polypeptides isolated from Achyranthes bidentata Blume (abbreviated as ABPP) on rat sciatic crush injury and to test the possible involvement of neurotrophic factors. After surgical crush injury, rats received daily intraperitoneal injection of 0.2 ml saline containing 2 mg ABPP, 1 μg nerve growth factor (NGF) or no additive. The results from walking track analysis, electrophysiological assessment and histological evaluation indicated that the repair outcomes by ABPP treatment were close to those by NGF treatment, but better than those by treatment with saline alone. The quantitative real-time RT-PCR was used to monitor the mRNA expression of growth associated protein in the crush nerves and the mRNA expression of NGF, brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), tyrosine kinase (Trk)A and TrkB in the dorsal root ganglia (DRGs) at L4–L6. The mRNA expression of these genes in the crush nerve sample and DRGs sample was higher after treatment with ABPP or NGF than after treatment with saline alone. Our findings suggest that ABPP might protect peripheral nerve against crush injury through stimulating release of neurotrophic factors and the other cytokines.     

神经生长因子与冻干异体神经桥接大鼠神经缺损的研究

实验采用冻干处理的异体神经与外源性神经生长因子（ＮＧＦ）结合来桥接大鼠的坐骨神经１．０ｃｍ的缺损。用雄性Ｗｉｓｔａｒ大鼠进行的四组实验结果表明：冻干处理的异体神经可降低其抗原性,但处理后并不损害雪旺氏细胞（ＳＣ）基底膜的完整性,在移植后可能成为轴突再生的通道和支架;外源性ＮＧＦ与冻干神经结合形成的复合体,可为神经的再生提供一个较好的微环境,具有成为理想桥接材料的可能性     

Lentiviral-mediated transfer of CDNF promotes nerve regeneration and functional recovery after sciatic nerve injury in adult rats

Peripheral nerve injury is often followed by incomplete and unsatisfactory functional recovery and may be associated with sensory and motor impairment of the affected limb. Therefore, a novel method is needed to improve the speed of recovery and the final functional outcome after peripheral nerve injuries. This report investigates the effect of lentiviral-mediated transfer of conserved dopamine neurotrophic factor (CDNF) on regeneration of the rat peripheral nerve in a transection model in vivo. We observed notable overexpression of CDNF protein in the distal sciatic nerve after recombinant CDNF lentiviral vector application. We evaluated sciatic nerve regeneration after surgery using light and electron microscopy and the functional recovery using the sciatic functional index and target muscle weight. HE staining revealed better ordered structured in the CDNF-treated group at 8 weeks post-surgery. Quantitative analysis of immunohistochemistry of NF200 and S-100 in the CDNF group revealed significant improvement of axonal and Schwann cell regeneration compared with the control groups at 4 weeks and 8 weeks after injury. The thickness of the myelination around the axons in the CDNF group was significantly higher than in the control groups at 8 weeks post-surgery. The CDNF group displayed higher muscle weights and significantly increased sciatic nerve index values. Our findings suggest that CDNF gene therapy could provide durable and stable CDNF protein concentration and has the potential to enhance peripheral nerve regeneration, morphological and functional recovery following nerve injury, which suggests a promising strategy for peripheral nerve repair.     

Fibrin matrices with affinity‐based delivery systems and neurotrophic factors promote functional nerve regeneration

Glial‐derived neurotrophic factor (GDNF) and nerve growth factor (NGF) have both been shown to enhance peripheral nerve regeneration following injury and target different neuronal populations. The delivery of either growth factor at the site of injury may, therefore, result in quantitative differences in motor nerve regeneration and functional recovery. In this study we evaluated the effect of affinity‐based delivery of GDNF or NGF from fibrin‐filled nerve guidance conduits (NGCs) on motor nerve regeneration and functional recovery in a 13 mm rat sciatic nerve defect. Seven experimental groups were evaluated consisting of GDNF or NGF and the affinity‐based delivery system (DS) within NGCs, control groups excluding the DS and/or growth factor, and nerve isografts. Groups with growth factor in the conduit demonstrated equivalent or superior performance in behavioral tests and relative muscle mass measurements compared to isografts at 12 weeks. Additionally, groups with GDNF demonstrated greater specific twitch and tetanic force production in extensor digitorum longus (EDL) muscle than the isograft control, while groups with NGF produced demonstrated similar force production compared to the isograft control. Assessment of motor axon regeneration by retrograde labeling further revealed that the number of ventral horn neurons regenerating across NGCs containing GDNF and NGF DS was similar to the isograft group and these counts were greater than the groups without growth factor. Overall, the GDNF DS group demonstrated superior functional recovery and equivalent motor nerve regeneration compared to the isograft control, suggesting it has potential as a treatment for motor nerve injury. Biotechnol. Bioeng. 2010;106: 970–979. © 2010 Wiley Periodicals, Inc.     

Synergistic Effects of Bone Mesenchymal Stem Cells and Chondroitinase ABC on Nerve Regeneration After Acellular Nerve Allograft in Rats

This study aimed to evaluate whether combination therapy of bone marrow stromal cells (BMSCs) transplantation and chondroitinase ABC (ChABC) treatment further enhances axonal regeneration and functional recovery after acellular nerve allograft repair of the sciatic nerve gap in rats. Eight Sprague–Dawley rats were used as nerve donors, and 32 Wistar rats were randomly divided into four groups: Group I: acellular rat sciatic nerve (ARSN) group; Group II: ChABC treatment; Group III: BMSCs transplantation; and Group IV: ChABC treatment and BMSCs transplantation. The results showed that compared with ARSN control group, BMSC transplantation promoted axonal regeneration, the secretion of neural trophic factors NGF, BDNF and axon angiogenesis in nerve graft. ChABC treatment degraded chondroitin sulfate proteoglycans in ARSN in vitro and in vivo and improved BMSCs survival in ARSN. The combination therapy caused much better beneficial effects evidenced by increasing sciatic function index, nerve conduction velocity, restoration rate of tibialis anterior wet muscle weight, and myelinated nerve number, but did not further boost the therapeutic effects on neurotrophic factor production, axon angiogenesis, and sensory functional recovery by BMSC transplantation. Taken together, for the first time, we demonstrate the synergistic effects of BMSC transplantation and BMSCs treatment on peripheral nerve regeneration, and our findings may help establish novel strategies for cell transplantation therapy for peripheral nerve injury.     

Neural Stem Cells Enhance Nerve Regeneration after Sciatic Nerve Injury in Rats

With the development of tissue engineering and the shortage of autologous nerve grafts in nerve reconstruction, cell transplantation in a conduit is an alternative strategy to improve nerve regeneration. The present study evaluated the effects and mechanism of brain-derived neural stem cells (NSCs) on sciatic nerve injury in rats. At the transection of the sciatic nerve, a 10-mm gap between the nerve stumps was bridged with a silicon conduit filled with 5?×?10⁵ NSCs. In control experiments, the conduit was filled with nerve growth factor (NGF) or normal saline (NS). The functional and morphological properties of regenerated nerves were investigated, and expression of hepatocyte growth factor (HGF) and NGF was measured. One week later, there was no connection through the conduit. Four or eight weeks later, fibrous connections were evident between the proximal and distal segments. Motor function was revealed by measurement of the sciatic functional index (SFI) and sciatic nerve conduction velocity (NCV). Functional recovery in the NSC and NGF groups was significantly more advanced than that in the NS group. NSCs showed significant improvement in axon myelination of the regenerated nerves. Expression of NGF and HGF in the injured sciatic nerve was significantly lower in the NS group than in the NSCs and NGF groups. These results and other advantages of NSCs, such as ease of harvest and relative abundance, suggest that NSCs could be used clinically to enhance peripheral nerve repair.     

Beneficial Effect of Metformin on Nerve Regeneration and Functional Recovery After Sciatic Nerve Crush Injury in Diabetic Rats

Neuroprotective effects of metformin have been increasingly recognized in both diabetic and non-diabetic conditions. Thus far, no information has been available on the potential beneficial effects of metformin on peripheral nerve regeneration in diabetes mellitus. The present study was designed to investigate such a possibility. Diabetes was established by a single injection of streptozotocin at 50 mg/kg in rats. After sciatic nerve crush injury, the diabetic rats were intraperitoneally administrated daily for 4 weeks with metformin (30, 200 and 500 mg/kg), or normal saline, respectively. The axonal regeneration was investigated by morphometric analysis and retrograde labeling. The functional recovery was evaluated by electrophysiological studies and behavioral analysis. It was found that metformin significantly enhanced axonal regeneration and functional recovery compared to saline after sciatic nerve injury in diabetic rats. In addition, metformin at 200 and 500 mg/kg showed better performance than that at 30 mg/kg. Taken together, metformin is capable of promoting nerve regeneration after sciatic nerve injuries in diabetes mellitus, highlighting its therapeutic values for peripheral nerve injury repair in diabetes mellitus.     

Evidence for a systemic regulation of neurotrophin synthesis in response to peripheral nerve injury

Up-regulation of neurotrophin synthesis is an important mechanism of peripheral nerve regeneration after injury. Neurotrophin expression is regulated by a complex series of events including cell interactions and multiple molecular stimuli. We have studied neurotrophin synthesis at 2?weeks time-point in a transvertebral model of unilateral or bilateral transection of sciatic nerve in rats. We have found that unilateral sciatic nerve transection results in the elevation of nerve growth factor (NGF) and NT-3, but not glial cell-line derived neurotrophic factor or brain-derived neural factor, in the uninjured nerve on the contralateral side, commonly considered as a control. Bilateral transection further increased NGF but not other neurotrophins in the nerve segment distal to the transection site, as compared to the unilateral injury. To further investigate the distinct role of NGF in regeneration and its potential for peripheral nerve repair, we transduced isogeneic Schwann cells with NGF-encoding lentivirus and transplanted the over-expressing cells into the distal segment of a transected nerve. Axonal regeneration was studied at 2?weeks time-point using pan-neuronal marker NF-200 and found to directly correlate with NGF levels in the regenerating nerve.     

神经生长因子对兔坐骨神经损伤后脊髓前角运动神经元乙酰胆碱酯酶的影响

钳夹损伤兔右坐骨神经,于损伤处注射蛇毒ＮＧＦ４００Ｂｕ／ｋｇ／日,损伤术后１,３,７天和２,３,４,６,８周动态观察脊髓腰段伤侧第Ⅸ板层外侧群的大型运动神经元的ＡＣｈＥ活性改变。结果表明术后１,３天实验组（指损伤给药组）和对照组（指损伤对照组）ＡＣｈＥ活性均下降（Ｐ＞００５）;术后１,２,３周对照组ＡＣｈＥ活性明显下降,而实验组ＡＣｈＥ活性逐渐趋于恢复（Ｐ＜００１）;术后６周实验组ＡＣｈＥ活性恢复至正常水平（Ｐ＜００１）。本研究显示蛇毒ＮＧＦ对坐骨神经损伤后脊髓前角运动神经元ＡＣｈＥ活性恢复有促进作用,从而对运动神经元可起一定的保护作用和促进恢复的作用